Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India-Japan Trade Talks Center On Quick Action On Drug Applications

This article was originally published in PharmAsia News

Executive Summary

Trade authorities in Japan and India are closing in on an agreement that would allow Indian generics to sell their wares in Japan. The India-Japan Comprehensive Economic Partnership Agreement is still being negotiated, but the office of India's prime minister's has discussed the talks with some Indian companies. India seeks Japanese decisions on its drug approval applications within one year, with an understanding the year would not include time Indian firms take to responds to regulatory questions. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts